| - Broglie MA, Jochum W, Michel A, Waterboer T, Foerbs D, Schoenegg R, Stöckli S,Pawlita M, Holzinger D. Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer. Oral Oncol 2017; 70:43-50.
- Broglie MA, Stöckli S, Sauter R, Pasche P, Reinhard A, de Leval L, Huber G F, Pezier TF, Soltermann A, Giger R, Arnold A, Dettmer M, Arnoux A, Müller M, Spreitzer S, Lang F, Lutchmaya M, Stauffer E, Espeli V, Martucci F, Bongiovanni M, Foerbs D, Jochum W. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery. Head Neck 2017; 39:2004-2015.
- Broglie MA, Soltermann A, Rohrbach D, Haile SR, Pawlita M, Studer G, et al. Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head Neck. 2013; 35(12): 1698-706.
- Broglie MA, Soltermann A, Haile SR, Roosli C, Huber GF, Schmid S, et al. Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16-positivity. Laryngoscope. 2013; 123(1): 164-70.
- Niederer-Wuest S, Jochum W, Förbs D, Brändle M, Bilz S, Clerici T, Oettli R, Müller J, Haile SR, Ess S, Stöckli SJ, Broglie MA. Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer. Surgery 2015; 157:119- 25.
|
|
